Categories

Colon cancer is the second-leading cause of cancer death in the United States. According to the American Cancer Society, one in…

Continue Reading

When it comes to cancer, it is often said that “an ounce of cancer prevention is worth a ton of cancer…

Continue Reading

Myriad Genetics has been in business for more than 27 years and we are a global leader in personalized medicine.  Click…

Continue Reading

Counsyl, Inc. has combined with Myriad Genetics’ Preventive Care business unit to form Myriad Women’s Health, Inc., a premier genetic screening…

Continue Reading

EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can…

Continue Reading

According to the American Cancer Society, 1 in 8 U.S. women will be diagnosed with breast cancer in their lifetime.  In…

Continue Reading

September is Prostate Cancer Awareness Month. According the American Cancer Society, more than 165,000 men will be diagnosed with prostate cancer…

Continue Reading

The biomedical innovation now happening in the molecular diagnostics industry is making it possible for clinicians to answer their patients’ four…

Continue Reading

Mental Health Month, Depression and GeneSight®    The GeneSight® genetic test has produced exciting news for patients diagnosed with depression.  A landmark…

Continue Reading

ColonCancerPoster_Thumbnail

In hereditary colon cancer, knowledge is power!  During the month of March, Myriad Genetics is demonstrating a strong commitment to preventing hereditary colon…

Continue Reading